These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11604046)

  • 1. Innovative therapies for sepsis.
    Krishnagopalan S; Dellinger RP
    BioDrugs; 2001; 15(10):645-54. PubMed ID: 11604046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The systemic inflammatory response syndrome.
    Weigand MA; Hörner C; Bardenheuer HJ; Bouchon A
    Best Pract Res Clin Anaesthesiol; 2004 Sep; 18(3):455-75. PubMed ID: 15212339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation inhibitors in the treatment of sepsis.
    Freeman BD; Buchman TG
    Expert Opin Investig Drugs; 2002 Jan; 11(1):69-74. PubMed ID: 11772322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems and perspective approaches to correction of mediator response in sepsis].
    Mironov PI; Rudnov VA
    Anesteziol Reanimatol; 1999; (3):54-9. PubMed ID: 10458039
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS).
    Horn KD
    QJM; 1998 Apr; 91(4):265-77. PubMed ID: 9666949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory therapies in sepsis.
    Kox WJ; Volk T; Kox SN; Volk HD
    Intensive Care Med; 2000; 26 Suppl 1():S124-8. PubMed ID: 10786969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Focal surgery, antibiotic therapy--and then? The role of rhAPC in sepsis].
    Spies C; Otter H; Zuckermann-Becker H; Kox WJ
    Kongressbd Dtsch Ges Chir Kongr; 2002; 119():834-43. PubMed ID: 12704933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential strategies for inflammatory mediator manipulation: retrospect and prospect.
    Fisher CJ; Zheng Y
    World J Surg; 1996 May; 20(4):447-53. PubMed ID: 8662133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical management of patients with sepsis].
    Weigand MA; Bardenheuer HJ; Böttiger BW
    Anaesthesist; 2003 Jan; 52(1):3-22. PubMed ID: 12577161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibodies against inflammatory mediators for the treatment of patients with sepsis].
    Matsubara T
    Nihon Rinsho; 2002 Mar; 60(3):578-84. PubMed ID: 11904976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammatory response syndrome and compensatory anti-inflammatory response syndrome in sepsis.
    van der Poll T; Meijers JC
    J Innate Immun; 2010; 2(5):379-80. PubMed ID: 20606408
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing, treating and managing patients with sepsis.
    Robson W; Newell J
    Nurs Stand; 2005 Aug 24-30; 19(50):56-64. PubMed ID: 16138619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical points for sepsis management at the patient bedside.
    Tulli G
    Minerva Anestesiol; 2003; 69(1-2):35-56, 56-65. PubMed ID: 12677162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for severe sepsis and septic shock.
    Sharma VK; Dellinger RP
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):395-403. PubMed ID: 16771617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.
    De Backer D
    Drug Saf; 2007; 30(11):995-1010. PubMed ID: 17973539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis and the systemic inflammatory response syndrome.
    Paterson RL; Webster NR
    J R Coll Surg Edinb; 2000 Jun; 45(3):178-82. PubMed ID: 10881485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation in sepsis: state of the art and future perspective.
    Antonopoulou A; Giamarellos-Bourboulis EJ
    Immunotherapy; 2011 Jan; 3(1):117-28. PubMed ID: 21174562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.